20 results
8-K
NUVA
Nuvasive Inc
8 May 08
NuVasive Signs Definitive Agreement to Acquire Osteocel Biologics Business from Osiris Therapeutics
12:00am
by the stockholders of Seller; and
expiration or termination of the applicable waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976
8-K
NUVA
Nuvasive Inc
29 Sep 11
Nuvasive Signs Agreement to Acquire Impulse Monitoring
12:00am
and regulatory actions, including the applicable waiting periods under the Hart-Scott-Rodino Antitrust Improvement Act; the risk that the Company may
8-K
EX-99.1
NUVA
Nuvasive Inc
3 Apr 23
Regulation FD Disclosure
9:37pm
transactions and stand- After aligning on the proposed exchange antitrust efforts, and voting industry trends and developments, alone path ratio of 0.75x … approve antitrust efforts and voting commitment was not accepted transaction; execute merger from Globus Medical’s Executive agreement Both parties continue
425
NUVA
Nuvasive Inc
3 May 23
Business combination disclosure
5:29pm
or termination of the applicable waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the “HSR Act”), Merger Sub will merge
8-K
NUVA
Nuvasive Inc
3 May 23
Other Events
5:25pm
waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the “HSR Act”), Merger Sub will merge with and into NuVasive
8-K
EX-99.1
7rsg4nkj0
29 Sep 11
Nuvasive Signs Agreement to Acquire Impulse Monitoring
12:00am
425
vqmmro8ya569hav
3 Apr 23
Business combination disclosure
9:39pm
425
7o5wwyrk6rx1w
3 Apr 23
Business combination disclosure
5:18pm
8-K
b86w3
3 Apr 23
Other Events
5:12pm
425
izr1yz0cp
3 Apr 23
Business combination disclosure
5:26pm
8-K
brn iqenofc
10 May 23
NuVasive Announces First Quarter 2023 Financial Results
4:09pm
8-K
EX-2.1
1wg3vz f5gmuwgytm
7 Oct 11
Announces Webcast and Conference Call of Third Quarter 2011 Results
12:00am
425
rafj8 gxbxxx
10 May 23
Business combination disclosure
4:11pm
- Prev
- 1
- Next